Prostate Cancer News on BioPortfolio

Monoclonal Antibodies Targeting Cancer

The NCI Cancer and Inflammation Program is seeking parties to license monoclonal antibodies against the insulinlike growth factor for the treatment of cancer.IC NCINIH Ref. No. E2122011

Pages